Biotech Values

[Whalatane]

OMER vs CCXI ..bladerunner .... they both have good programs but I give the nod to OMER ...partly on the basis on comments such as the following


“The clinical responses in my IgA nephropathy patients treated with OMS721 are truly impressive,” stated Geoffrey Block, M.D., Director of Clinical Research at Denver Nephrology.

“These are patients with significant renal impairment who had not responded to steroid therapy. Each OMS721-treated patient substantially improved while markedly reducing or stopping steroid use.

Equally impressive is that, after OMS721 treatment was completed, a legacy effect of continued improvement was observed in each patient. I look forward to participating in the Phase 3 clinical trial and to working with Omeros to make this important drug broadly available to patients.”

---------------------------
Dr Block ( Denver Nephrology ) is known and highly respected by some in my wifes Renal dept .

Kiwi